SJS Investment Consulting’s Corcept Therapeutics CORT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $661 | Sell |
9
-7
| -44% | -$514 | ﹤0.01% | 1014 |
|
2025
Q1 | $1.83K | Hold |
16
| – | – | ﹤0.01% | 763 |
|
2024
Q4 | $807 | Sell |
16
-4
| -20% | -$202 | ﹤0.01% | 1082 |
|
2024
Q3 | $926 | Hold |
20
| – | – | ﹤0.01% | 1098 |
|
2024
Q2 | $650 | Hold |
20
| – | – | ﹤0.01% | 1204 |
|
2024
Q1 | $504 | Sell |
20
-1
| -5% | -$25 | ﹤0.01% | 1285 |
|
2023
Q4 | $683 | Sell |
21
-3
| -13% | -$98 | ﹤0.01% | 1118 |
|
2023
Q3 | $654 | Buy |
24
+4
| +20% | +$109 | ﹤0.01% | 1109 |
|
2023
Q2 | $445 | Buy |
20
+6
| +43% | +$134 | ﹤0.01% | 1202 |
|
2023
Q1 | $304 | Sell |
14
-3
| -18% | -$65 | ﹤0.01% | 1282 |
|
2022
Q4 | $345 | Buy |
17
+4
| +31% | +$81 | ﹤0.01% | 1316 |
|
2022
Q3 | $0 | Buy |
+13
| New | – | ﹤0.01% | 1127 |
|
2022
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 814 |
|